English
Français
Deutsch
Italiano
Português
Русский
Español
简体中文
日本語
By Adria Calatayud
Bayer shares fell sharply after the company stopped a late-stage study for a cardiovascular drug early due to lack of efficacy and was ordered to pay $1.56 billion in a lawsuit relating to its Roundup weedkiller.
At 0928 GMT, shares in the German pharmaceutical-and-agricultural group traded 20% lower at EUR33.15, at levels…
Read the full article here
